--- title: "Nexentis Technologies (NXTS) stock and investor profile" url: "https://aibio.space/companies/nexentis-technologies/" publisher: "aibio.space (Biotech Investor Relations News)" summary: "Nexentis Technologies Inc. (NASDAQ: NXTS), United States. Listing facts, related biotech companies and news on aibio.space." --- NXTS Nexentis Technologies Inc. NASDAQ · United States # Nexentis Technologies (NXTS) news Nexentis Technologies Inc. is a public biotech or pharmaceutical company listed on NASDAQ under the ticker NXTS, recorded under United States. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them. ## Latest Nexentis Technologies news We have not published a story on Nexentis Technologies yet. When there is news, it will appear here. ## Nexentis Technologies at a glance - **Ticker**: NXTS - **Listing**: NASDAQ - **Country**: United States - **Cash, Jun 30, 2026**: $8.9 million ### Related companies - [Cannabis Bioscience International Holdings](https://aibio.space/companies/cannabis-bioscience-international/) OTC: CBIH - [CANNAPHARMARX, INC.](https://aibio.space/companies/cannapharmarx/) OTC: CPMD - [GLAUKOS](https://aibio.space/companies/glaukos/) NYSE: GKOS - [Mountain Crest Acquisition Corp. V](https://aibio.space/companies/mountain-crest-acquisition-v/) OTC: MCAG - [Envoy Medical](https://aibio.space/companies/envoy-medical/) NASDAQ: COCH - [MDxHealth SA](https://aibio.space/companies/mdxhealth/) NASDAQ: MDXH - [MSA Safety](https://aibio.space/companies/msa-safety/) NYSE: MSA - [LogicMark](https://aibio.space/companies/logicmark/) OTC: LGMK ### Also on NASDAQ - [Ovid Therapeutics](https://aibio.space/companies/ovid-therapeutics/) OVID - [Veraxa Biotech](https://aibio.space/companies/veraxa-biotech/) VRXA - [Agenus](https://aibio.space/companies/agenus/) AGEN - [Trevi Therapeutics](https://aibio.space/companies/trevi-therapeutics/) TRVI - [PDS Biotechnology](https://aibio.space/companies/pds-biotechnology/) PDSB - [LB Pharmaceuticals](https://aibio.space/companies/lb-pharmaceuticals/) LBRX ## Nexentis Technologies annual financials | Line | FY2025 | FY2024 | |---|---|---| | Research and development | [$179,000](https://www.sec.gov/Archives/edgar/data/1789192/000149315226014183/) | [$369,000](https://www.sec.gov/Archives/edgar/data/1789192/000164117225001513/) | | Net income (loss) | [-$4.0 million](https://www.sec.gov/Archives/edgar/data/1789192/000149315226014183/) | [-$5.2 million](https://www.sec.gov/Archives/edgar/data/1789192/000149315226014183/) | | Cash from operations | [-$3.8 million](https://www.sec.gov/Archives/edgar/data/1789192/000149315226014183/) | [-$3.4 million](https://www.sec.gov/Archives/edgar/data/1789192/000149315226014183/) | | Cash and equivalents | [$3.8 million](https://www.sec.gov/Archives/edgar/data/1789192/000149315226037757/) | [$1.9 million](https://www.sec.gov/Archives/edgar/data/1789192/000149315226014183/) | | Short-term investments | [$239,000](https://www.sec.gov/Archives/edgar/data/1789192/000149315226037757/) | [$234,000](https://www.sec.gov/Archives/edgar/data/1789192/000164117225001513/) | Latest balance sheet, Jun 30, 2026 (10-Q): cash and equivalents $7.6 million, plus short-term investments of $1.3 million, $8.9 million in all. Figures as reported to the SEC in XBRL; each one links to its filing. Not adjusted, not investment advice. ## Questions about Nexentis Technologies What is the ticker symbol of Nexentis Technologies? Nexentis Technologies Inc. trades under the ticker NXTS on NASDAQ. Where is Nexentis Technologies listed? Nexentis Technologies Inc. is listed on NASDAQ. Which country or territory is Nexentis Technologies listed under? Our directory records Nexentis Technologies Inc. under United States. Does aibio.space cover Nexentis Technologies? aibio.space lists Nexentis Technologies Inc. among 2,820 public biotech companies and publishes its news here as stories appear. Is Nexentis Technologies profitable? Nexentis Technologies Inc. reported a net loss of $4.0 million for the fiscal year ended Dec 31, 2025, and used $3.8 million of cash in operations, per its annual report to the SEC. How much does Nexentis Technologies spend on research and development? $179,000 in the fiscal year ended Dec 31, 2025, per its annual report. How much cash does Nexentis Technologies have? $8.9 million in cash and short-term investments at Jun 30, 2026, per its 10-Q. ## Investor discussion: Nexentis Technologies Members talk about Nexentis Technologies (NXTS). Reader posts, not aibio.space reporting, and not investment advice. Rules 1. **Securities violations are strictly forbidden.** No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information. 2. **Say whether you hold the stock.** Every post states long, short or no position. 3. **No paid or sponsored posts.** Do not post for anyone who pays or rewards you. 4. **No buy or sell calls and no price targets.** 5. **No accusations of crime or fraud against named people** unless you link a court filing or a regulator's release that makes them. 6. **No personal details and no spam.** No links at all for your first 7 days as a member. Posts that break the rules may be deleted without notice, and the account restricted or closed. See the [terms](https://aibio.space/terms/#discussion) and the [privacy policy](https://aibio.space/privacy/#discussion). ## Capital-markets timeline Financings, listing notices, splits, legal actions and other investor events at Nexentis Technologies, newest first. Each line links the filing it comes from. 1. 2026-10-19 Financings Reported an unregistered sale of its securities. SEC Form 8-K (Items 3.02,5.02). [Source](https://www.sec.gov/Archives/edgar/data/1789192/000149315226047578/form8-k.htm) 2. 2026-10-06 Financings Reported a financing. SEC Form 8-K (Items 1.01,9.01). [Source](https://www.sec.gov/Archives/edgar/data/1789192/000149315226045885/form8-k.htm) 3. 2026-09-03 Listings Reported a notice from its stock exchange about continued listing requirements. SEC Form 8-K (Items 3.01). [Source](https://www.sec.gov/Archives/edgar/data/1789192/000149315226041358/form8-k.htm) 4. 2026-08-06 Legal Reported a change of independent auditor. SEC Form 8-K (Items 4.01,9.01). [Source](https://www.sec.gov/Archives/edgar/data/1789192/000149315226036335/form8-k.htm) 5. 2026-06-23 Financings Filed a final prospectus for a securities offering. SEC Form 424B5. [Source](https://www.sec.gov/Archives/edgar/data/1789192/000149315226029724/form424b5.htm) 6. 2026-04-30 Listings Reported a shareholder vote on a reverse stock split or more authorized shares. SEC Form 8-K (Items 5.07). [Source](https://www.sec.gov/Archives/edgar/data/1789192/000149315226020509/form8-k.htm) ## Stock chart Price chart and quote supplied by TradingView, delayed as the exchange requires. It loads only if you choose to show it. Information only, not investment advice. [Open NASDAQ:NXTS on TradingView](https://www.tradingview.com/symbols/NASDAQ-NXTS/). ## Listing details Nexentis Technologies Inc. is a public biotech or pharmaceutical company listed on NASDAQ under the ticker NXTS, recorded under United States. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them. - **Company**: Nexentis Technologies Inc. - **Ticker**: NXTS - **Listing**: NASDAQ - **Country or territory**: United States Listing facts come from our company directory, researched on October 22, 2026. A listing record does not certify that a security currently trades. [Tell us about a change](https://aibio.space/reputation/#update). Work at this company? [Claim this page](https://aibio.space/claim/). Published and maintained by aibio.space. Not investment advice. [How we work](https://aibio.space/disclosures/). Who manages this page **This page is managed by aibio.space.** The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. [How we work](https://aibio.space/disclosures/#paid) · [Terms](https://aibio.space/terms/#news) · [Request a correction](https://aibio.space/reputation/#update) --- Source page: https://aibio.space/companies/nexentis-technologies/. Facts in aibio.space stories are checked against company filings and releases; opinion is labelled. Cite as: aibio.space, "Nexentis Technologies (NXTS) stock and investor profile", 2026-10-31, https://aibio.space/companies/nexentis-technologies/